(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

TRATAMENTO DE CÂNCER

Em AnáliseInvention PatentPCT · EP2018052694

Application data

Number

112019016043

Type

Invention Patent

Filing

02/02/2018

Publication

03/31/2020

PCT

EP2018052694

Progress at the INPI

Under appeal
  1. Filing02/02/18
  2. Publication03/31/20
  3. Examination
  4. Allowance
  5. Grant
  6. In force

The application is under appeal: the INPI has yet to review the decision.

Leave your contact and we will alert you

We track INPI publications and let you know as soon as this case moves.

We use your details only for this alert.

Latest action published by the INPI: 04/15/2025. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

JANSSEN PHARMACEUTICA NV

BE

See this company's full portfolio

Inventors

A. A. (pessoa física)

US

A. S. (pessoa física)

BE

J. R. (pessoa física)

ES

K. S. (pessoa física)

BE

P. P. (pessoa física)

BE

Y. L. (pessoa física)

FR

Technical data

Priority claims

EP

17209098.7 · 12/20/2017

US

62/455,211 · 02/06/2017

Abstract

A presente invenção refere-se a um método para o tratamento de câncer com erdafitinib.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Petição de recurso

#12.2

Recurso: 870250027797 - 7/4/2025

04/15/2025

RPI 2832

Indeferimento

#9.2

02/04/2025

RPI 2822

Conhecimento de parecer técnico

#7.1

10/22/2024

RPI 2807

Parecer de pré-exame

#6.23

07/26/2022

RPI 2690

Adição na publicação

#15.35

10/13/2021

RPI 2649

Notificação de entrada na fase nacional - PCT

#1.3

03/31/2020

RPI 2569

Alteração de dados cadastrais

#1.1

08/13/2019

RPI 2536

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.